Gökçen Orhan

Gökçen Orhan

Auto-generated profile, based on publicly available information

Gökçen Orhan

Department of Cardiovascular Surgery, Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital, Istanbul, Turkey

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2020 in Journal of Vascular Surgery: Venous and Lymphatic Disorders
Verified
Journal Article
Closed access
HKHüseyin Kuplay
Hüseyin Kuplay
SESevinç Bayer Erdoğan
Sevinç Bayer Erdoğan
MBMurat Bastopcu
Murat Bastopcu
GAGökhan Arslanhan
Gökhan Arslanhan
DBDevlet Burak Baykan
Devlet Burak Baykan
GOGökçen Orhan
Gökçen Orhan

1 January 2006 in Heart and Vessels
Verified
Journal Article
Closed access
PDF file
GOGokcen Orhan
Gokcen Orhan
NYNihan Yapici
Nihan Yapici
MYMeral Yuksel
Meral Yuksel
MSMurat Sargin
Murat Sargin
ŞŞŞahın Şenay
Şahın Şenay
SASerap Aykut Aka
Serap Aykut Aka

1 February 2004 in European Journal of Cardio-Thoracic Surgery
Verified
Journal Article
Closed access
GOG Orhan
G Orhan
Obesity is a major public health problem with an increasing prevalence. Although coronary artery bypass grafting (CABG) operations are now performed with low morbidity and mortality rates, obesity is still assumed to be an important risk factor for morbidity and mortality at these operations but there is no precise approach to define it as a risk factor. The aim of this study is to evaluate the effects of obesity on the clinical outcome of the CABG operations. A total of 1206 patients, who underwent isolated CABG operation under cardiopulmonary bypass were evaluated retrospectively. The patients were divided into three groups. Group I was normal weight, with body mass index (BMI) of 18-24.9 kg/m(2), group II was overweight, with a BMI of 25-29.9 kg/m(2), and group III was obese, with a BMI of >30 kg/m(2). The clinical data of three groups were evaluated in aspects of postoperative morbidity and mortality. Except for the superficial wound infections, there were no differences in postoperative mortality and morbidity rates between the three groups. Obesity was not found to be an important risk factor for postoperative morbidity and mortality. Despite the perception that obesity increases the risk of mortality and morbidity in CABG operations, the clinical outcome of these patients are not so different from other patients. We may say that obese patients can be safely operated.

1 January 2008 in Acta Chirurgica Belgica
Verified
Journal Article
Closed access
BOB. Ozay
B. Ozay
EKE. Kurc
E. Kurc
GOG. Orhan
G. Orhan
OYO. Yucel
O. Yucel
SSS. Senay
S. Senay
SAS. Aykut Aka
S. Aykut Aka
Objective : The goal was to review our experience in the management of carotid body tumours. Material and methods : A retrospective study was performed of patients in whom carotid body tumour was diagnosed between 1998 and 2005. Data were retrieved from hospital discharge files. Results : Fourteen patients were operated on. There were five patients in Shamblin class I, 4 in class II, and 5 in class III. Duplex examination was performed in all patients. Computerized tomography scans were performed in eight (57%) patients and magnetic resonance imaging scans in five patients (36%). Angiography was performed in all patients, preoperative embolization was attempted in 5 (36%). The blood loss for these patients was not less than for those without embolization. Three patients (21%) had postoperative cranial nerve deficits. All the deficits resolved. The internal carotid artery was injured in two patients and the external carotid artery was injured in three patients (36%). No stroke occured. Conclusion : Surgical resection is the treatment of choice for carotid body tumours. Observation of these tumours is not recommended because progressive growth is associated with increased risk of neurological deficits. Early surgical management is recommended to avoid neurological deficit due to a Shamblin class III tumour. We also do not recommend embolization.

21 May 2007 in Heart and Vessels
Verified
Journal Article
Closed access
PDF file
ZTZeynep Tartan
Zeynep Tartan
GOGokcen Orhan
Gokcen Orhan
HKHulya Kasıkçioglu
Hulya Kasıkçioglu
HUHuseyin Uyarel
Huseyin Uyarel
SUSennur Unal
Sennur Unal
NCNese Cam
Nese Cam

12 May 2010 in Angiology
Verified
Journal Article
Closed access
PDF file
UFUgur Filizcan
Ugur Filizcan
EKErol Kurc
Erol Kurc
SCSebnem Cetemen
Sebnem Cetemen
OSOzer Soylu
Ozer Soylu
HAHakki Aydogan
Hakki Aydogan
IYIbrahim Yekeler
Ibrahim Yekeler
The use of coronary artery bypass grafting (CABG) in primary treatment of acute myocardial infarction is still debated. We evaluated the predictors of mortality in patients undergoing primary CABG for ST-elevated myocardial infarction (STEMI). Between January 2003 and January 2008, all patients referred to our institution with STEMI who did not qualify for primary angioplasty and required CABG were included in this study. Survivors and nonsurvivors were compared retrospectively in terms of demo-graphics, preoperative, intraoperative, and postoperative characteristics. Preoperatively confirmed cases of STEMI (n = 150) were included in the analysis. There were 114 survivors and 36 nonsurvivors. In-hospital mortality rate was 22%. In Cox regression analysis age, cardiogenic shock (Killip ≥3), preoperative cardiac troponin levels, preoperative use of intra-aortic balloon counterpulsation (IABP), previous myocardial infarction, and percutaneous coronary intervention were independent predictors of in-hospital mortality. After multivariate analysis, factors predicting in-hospital mortality were age, preoperative cardiac troponin levels, and preoperative IABP. Age, preoperative cardiac troponin levels, and preoperative IABP use were predictive factors of in-hospital mortality in patients undergoing primary CABG for STEMI.